Hemogenyx Pharmaceuticals Plc
HEMO.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£5,004 | -£2,806 | -£3 | -£2,370 |
| Dep. & Amort. | £314 | £318 | £0 | £326 |
| Deferred Tax | £0 | £0 | £0 | £634 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £583 | £569 | £67 | -£793 |
| Other Non-Cash | £324 | £136 | -£2,415 | -£488 |
| Operating Cash Flow | -£3,783 | -£1,783 | -£2 | -£2,775 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£4 | -£13 | £0 | -£104 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £264 | -£12 | £17 | £0 |
| Investing Cash Flow | £260 | -£25 | £17 | -£104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£346 | £0 | -£318 | £0 |
| Stock Issued | £2,018 | £552 | £3,160 | £1,170 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | -£317 | £0 | -£321 |
| Financing Cash Flow | £1,672 | £235 | £2,843 | £849 |
| Forex Effect | £1,919 | £90 | -£114 | £107 |
| Net Chg. in Cash | £67 | -£1,483 | £395 | -£1,837 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £159 | £1,643 | £1,248 | £2,533 |
| End Cash | £227 | £159 | £1,643 | £1,248 |
| Free Cash Flow | -£3,787 | -£1,797 | -£2 | -£2,879 |